Related Experiment Video
Updated: May 26, 2025

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells
Published on: November 2, 2017
SUMOylated hnRNPM suppresses PFKFB3 phosphorylation to regulate glycolysis and tumorigenesis
Ya-Xian Zhong1, Huan-Bin Zhao2, Meng-Han Lian3
1Institute of Aging & Tissue Regeneration, Stress and Cancer Research Unit of Chinese Academy of Medical Sciences (No. 2019RU043), State Key Laboratory of Systems Medicine for Cancer, Ren-Ji Hospital, Shanghai Jiao Tong University School of Medicine (SJTU-SM), Shanghai, 200127, China; Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, SJTU-SM, Shanghai, 200025, China.
Abstract:
Heterogeneous nuclear ribonucleoprotein M (hnRNPM), a splicing regulatory factor with a majority of studies focused on its RNA-binding properties and effects on splicing outcome, is implicated in the progression of various kinds of human cancers, but its mechanisms remain largely enigmatic. Applying the global SUMOylated proteomic screening in colorectal cancer cells, herein we find that hnRNPM is SUMOylated at lysine 17 and Sentrin-specific protease 1 (SENP1) is essential for its de-SUMOylation. Although hnRNPM SUMOylation does not affect its known pre-mRNA splicing-related effects, more intriguingly, it remarkably influences lactate production. Mechanistically, SUMOylated hnRNPM interacts with 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) to affect its localization and inhibit its phosphorylation, thus suppressing glycolysis. Accordingly, SUMO-deficient hnRNPM promotes colorectal cancer cell proliferation and tumorigenesis in mice. Also, a negative correlation between hnRNPM SUMOylation and SENP1 expression or phosphorylated PFKFB3 levels can be found in CRC patient samples. These findings not only enhance our understanding of the multifaceted roles of hnRNPM in cancer biology but also open new avenues for the development of targeted therapies aimed at modulating hnRNPM SUMOylation.
Insights
SUMOylation of heterogeneous nuclear ribonucleoprotein M (hnRNPM) regulates colorectal cancer by inhibiting glycolysis and lactate production. This novel mechanism impacts tumor growth and offers new therapeutic targets.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Heterogeneous nuclear ribonucleoprotein M (hnRNPM) is a splicing factor involved in cancer, but its precise mechanisms are unclear.
- Previous research focused on hnRNPM's RNA-binding and splicing roles.
Purpose of the Study:
- To investigate the non-splicing roles of hnRNPM in colorectal cancer.
- To identify post-translational modifications of hnRNPM in colorectal cancer cells.
Main Methods:
- Global SUMOylated proteomic screening in colorectal cancer cells.
- Interaction studies between hnRNPM, SENP1, and PFKFB3.
- In vivo tumorigenesis assays in mice.
- Analysis of patient samples for hnRNPM SUMOylation and related protein levels.
Main Results:
- hnRNPM is SUMOylated at lysine 17, and SENP1 mediates its de-SUMOylation.
- hnRNPM SUMOylation inhibits glycolysis by interacting with PFKFB3, affecting its localization and phosphorylation, thereby suppressing lactate production.
- SUMO-deficient hnRNPM promotes colorectal cancer cell proliferation and tumorigenesis in mice.
- A negative correlation exists between hnRNPM SUMOylation and SENP1 expression or phosphorylated PFKFB3 levels in colorectal cancer patient samples.
Conclusions:
- hnRNPM SUMOylation plays a critical role in regulating colorectal cancer cell metabolism and growth independent of its splicing functions.
- Modulating hnRNPM SUMOylation presents a potential therapeutic strategy for colorectal cancer.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Negative Regulator Molecules

